Draft:Alexander G. Obukhov

molecular physiology, and vascular biology.^[1] Since 1986, Obukhov published research articles, with the most notable ones published in academic journals such as Nature,^[2] Journal of Biological Chemistry,^[3] EMBO Journal,^[4] Journal of Cell Biology,^[5] Proceedings of the National Academy of Sciences of the United States of America,^[6] and Neuron^[7]. Obukhov's research later evolved to feature multiple fields including neurophysiology, traumatic brain injury, pain, and atherosclerosis

Freien Universität Berlin (Berlin, Germany) where he studied the biophysical properties of just cloned Transient Receptor Potential (TRP) Channels. In the laboratory of Dr. Schultz, Obukhov continued mastering his skills as an electrophysiologist and also started learning Pharmacology and Molecular Biology. After completing the Humboldt Fellowship at the end of 1994, Obukhov continued his research of TRP channels in the laboratory of Dr. Schultz until 1999. While working in the Schultz laboratory, Obukhov with his colleagues provided first evidence that TRP proteins are ion channels by recording their single-channels activity.^[4] During this period, Obukhov published four of his most cited academic publications.^{[2][5][7][13]} In 1999, Dr. Obukhov moved to the USA where he initially worked at New Jersey Medical School of the University of Medicine and Dentistry of NJ (Newark, NJ) as an Instructor and then as a Research Assistant Professor^[14]. In 2006, Obukhov moved to Indianapolis, Indiana, USA to work for the Indiana University School of Medicine - Indianapolis as an Assistant Professor and then as an Associate Professor^[15]. The laboratory of Dr. Obukhov continues investigating the molecular physiology of TRP channels.^[3] Additionally, Dr. Obukhov studies the mechanisms of metabolic syndrome-associated atherosclerosis progression.^[16]